Trade CGEN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Compugen Ltd. (CGEN) is trading at US$2.49, up 1.22% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$247.71M. Over the past 52 weeks, CGEN has traded between US$1.30 and US$3.24. On Syfe you can trade CGEN with $0 commission and add it to your watchlist.
| Previous close | US$2.46 |
|---|---|
| Market cap | US$247.71M |
| 52-week range | US$1.30 – US$3.24 |
| Volume | 127.6K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Compugen Ltd.
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Year: 2000
Compugen Files $400 Million Mixed Shelf
May 18, 8:43 PM · MT Newswires
Compugen Ltd. (CGEN) stock is trading at US$2.49, +1.22% from the previous close of US$2.46.
The market cap for Compugen Ltd. (CGEN) stock is approximately US$247.71M.
The 52-week high for Compugen Ltd. (CGEN) stock is US$3.24.
The 52-week low for Compugen Ltd. (CGEN) stock is US$1.30.
Compugen Ltd. (CGEN) does not currently pay a dividend.
Stay on top of CGEN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
